Philadelphia Pharmaceuticals Company (ASE: PHIL)
Health Care · Pharmaceuticals · JO
JD2.00
+5.26% today · +29.0% 1Y
Philadelphia Pharmaceuticals Company (ASE: PHIL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $21.16M.
Over the last twelve months the share price has gained 29.0%, trading between 1.50 and 2.01.
Tweenvest scores Philadelphia Pharmaceuticals Company across four factors: quality 78/100, value 30/100, growth 50/100. Its strongest factor is quality.
PHIL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.16M
- Revenue (TTM)
- $12.65M
- P/E
- 14.15
- EPS
- 0.14
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- JD2.01
- 52-week low
- JD1.50
- Avg volume (3M)
- —
- Shares outstanding
- 7.50M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Accretion Pharmaceuticals LimitedNSEI: ACCPL | $21.70M | Rs188.95 | -7.06% |
| Accretion Nutraveda LimitedBSE: 544694 | $21.69M | Rs290.00 | -4.92% |
| Public Joint-Stock Company "Pharmsynthez"MISX: LIFE | $21.52M | RUB— | — |
| Rubicon Organics Inc.TSXV: ROMJ | $21.31M | CA$0.45 | +2.27% |
| Coral Laboratories LimitedBSE: 524506 | $21.12M | Rs572.25 | +4.31% |
| MediPharm Labs Corp.TSX: LABS | $20.96M | CA$0.07 | 0.00% |
| Universe Pharmaceuticals INCNasdaqCM: UPC | $20.85M | $4.13 | -0.48% |
| Syschem (India) LimitedBSE: 531173 | $20.83M | Rs37.60 | +8.05% |
Figures last refreshed Oct 11, 2026.